A tirzepatide prescription is required to access Mounjaro for type 2 diabetes or Zepbound for chronic weight management. You can get one from a primary care physician, endocrinologist, obesity-medicine specialist, or a state-licensed telehealth clinician after a clinical evaluation that confirms eligibility and rules out contraindications.
What Tirzepatide Is and How It Is Sold
Tirzepatide is a once-weekly injectable that activates both the GIP and GLP-1 receptors. The same molecule is sold under two brand names in the United States: Mounjaro for type 2 diabetes and Zepbound for chronic weight management. Both are manufactured by Eli Lilly. According to the FDA label, dosing starts at 2.5 mg weekly for four weeks and titrates up monthly to a maintenance dose between 5 mg and 15 mg.
Because tirzepatide is a federally regulated prescription drug, you cannot legally buy branded tirzepatide without a clinician’s order. Compounded versions exist in a separate gray-market space and are not FDA approved. Our broader prediabetes treatment overview discusses where injectable therapy fits among other options.
Who Qualifies for a Tirzepatide Prescription
Eligibility depends on which indication your clinician is treating.
Mounjaro (Type 2 Diabetes)
Mounjaro is FDA approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. Most insurers require documentation of a confirmed type 2 diabetes diagnosis, an A1C result, and prior trial of metformin.
Zepbound (Chronic Weight Management)
Zepbound is approved for adults with a body mass index of 30 or higher, or 27 or higher with at least one weight-related comorbidity such as hypertension, type 2 diabetes, dyslipidemia, obstructive sleep apnea, or cardiovascular disease. The FDA also approved Zepbound for moderate-to-severe obstructive sleep apnea in adults with obesity in 2024.
Where to Get a Tirzepatide Prescription
Several paths are common in 2025-2026.
- Primary care physician. Often the easiest first step if you already have a relationship and meet criteria.
- Endocrinologist. Useful for complex diabetes or pituitary, thyroid, or adrenal concerns.
- Obesity-medicine specialist. Board certified by the American Board of Obesity Medicine; experienced with prior authorization.
- Telehealth platform. Many state-licensed services prescribe tirzepatide after a video visit, intake form, and lab review.
- Weight management or bariatric clinic. Often integrate dietitians and behavioral support.
What Happens at the Visit
The clinician will typically review your medical history, weight history, prior weight-loss attempts, and family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN 2). Tirzepatide carries an FDA boxed warning for thyroid C-cell tumors. Other contraindications include hypersensitivity to tirzepatide. Caution applies for personal history of pancreatitis, severe gastroparesis, gallbladder disease, or pregnancy.
Expected labs may include A1C, fasting glucose, comprehensive metabolic panel, and lipid panel. Some clinicians also check thyroid function and vitamin D.
Prior Authorization and Insurance
Most commercial insurers require a prior authorization (PA) before paying for a tirzepatide prescription. The PA usually documents:
- Diagnosis (T2D ICD-10 codes for Mounjaro; obesity codes for Zepbound)
- BMI and comorbidities
- Prior medication trials and outcomes
- Documentation of a comprehensive lifestyle program
Approval timelines range from 24 hours to two weeks. Denials can usually be appealed with additional documentation.
| Brand | Indication | Typical PA Requirements |
|---|---|---|
| Mounjaro | Type 2 diabetes | A1C, ICD-10 diagnosis, prior metformin trial |
| Zepbound | Obesity / OSA | BMI, comorbidity, lifestyle program documentation |
Savings Programs and Out-of-Pocket Cost
The list price for a 28-day supply runs roughly $1,000-$1,300. Eli Lilly’s savings card may bring monthly cost as low as $25 for commercially insured patients with coverage, with higher caps for commercially insured patients without coverage. Government insurance (Medicare, Medicaid, TRICARE) is excluded from these programs. For uninsured cash payers, Lilly Direct sells single-dose Zepbound vials at lower prices than the autoinjector pen.
What to Expect After You Get the Prescription
Most prescribers titrate the dose monthly to balance efficacy and tolerability. Many people experience nausea, constipation, or fatigue during the first week of each new dose. Plan for follow-up visits at 4, 12, and 24 weeks. If you also need glucose monitoring guidance, our overview of the A1C test walks through the standard targets.
The Bottom Line
A tirzepatide prescription is not endorsement; it is a tool that can substantially improve glucose control and weight when paired with lifestyle change. The path to a prescription includes a clinical visit, eligibility check, contraindication screen, prior authorization, and a savings-program review. Talk to your clinician about whether tirzepatide is appropriate for your medical history.
Medical disclaimer: This article is for educational purposes only and is not medical advice. Always consult your physician or a qualified healthcare provider before starting, stopping, or changing any medication or treatment plan.
